MAK (Male germ cell-Associated Kinase) is a serine/threonine protein kinase belonging to the MAP kinase family. It contains a conserved TDY motif (Threonine-Aspartate-Tyrosine) at positions 157-159. Phosphorylation at Y159 occurs as part of a dual phosphorylation event on this TDY motif that is crucial for full MAK kinase activity. Studies have shown that when the TDY motif is mutated, phosphorylation activity on substrates like MBP (Myelin Basic Protein) is dramatically reduced to levels similar to inactive MAK mutants . The Y159 phosphorylation site is conserved across human, mouse, and rat species, suggesting its evolutionary importance in MAK function .
Phospho-MAK (Y159) antibodies are validated for several applications:
While these are the validated applications, researchers should perform optimization for their specific experimental conditions. The antibody has been tested with human cell lines including HepG2 and MCF-7, showing specific detection of MAK at approximately 70 kDa .
For maximum stability and activity retention:
Avoid repeated freeze-thaw cycles by preparing aliquots before freezing
The antibody is typically supplied in PBS buffer containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide
Some preparations may use PBS without Mg²⁺ and Ca²⁺ at pH 7.4, with 150 mM NaCl, 0.02% sodium azide, and 50% glycerol
When designing experiments to study MAK Y159 phosphorylation, consider the following approach:
Positive controls: Include samples from cells known to express phosphorylated MAK, such as HepG2 or MCF-7 cell lysates . These cell lines have been validated for MAK expression and can serve as appropriate positive controls.
Negative controls: Consider using:
Stimulation conditions: MAK phosphorylation can be induced through various signaling pathways. The search results indicate connections to FGFR signaling pathways, so consider FGF treatment to observe dynamic changes in phosphorylation .
Kinase activity correlation: Plan experiments that correlate Y159 phosphorylation with MAK kinase activity using in vitro kinase assays with MBP as substrate .
For optimal detection of phosphorylated MAK at Y159:
Lysis buffer composition: Use buffer containing 50mM Tris-HCl pH7.5, 150mM NaCl, 0.5% Triton X-100, 10% glycerol, 1mM EDTA, plus phosphatase and protease inhibitors .
Fractionation considerations: Consider nuclear and cytoplasmic fractionation when studying MAK, as its localization may change based on phosphorylation status. Commercial reagents like NE-PER Nuclear and Cytoplasmic extraction reagents can be used for this purpose .
Immunoprecipitation protocol: For enrichment of phospho-MAK:
Research indicates that MAK is overexpressed in prostate cancer cell lines and clinical specimens . To investigate this connection:
Expression profiling: Compare phospho-MAK (Y159) levels across normal prostate tissue and progressive stages of prostate cancer to establish correlation with disease progression.
Functional studies: Use the antibody to monitor changes in MAK phosphorylation status following treatment with anti-cancer agents or genetic manipulation of cancer-related pathways.
Pathway analysis: Since MAK interacts with cell cycle regulation, examine the relationship between phospho-MAK (Y159) and cell cycle markers such as Cyclin B1, phospho-histone H3 Serine 10, Aurora A, and PLK1 .
Mechanistic investigation: The antibody can be used to determine if increased phosphorylation at Y159 contributes to MAK overactivation in cancer contexts, potentially through in vitro kinase assays comparing phosphorylation levels and kinase activity.
The research data shows interesting connections between Fibroblast Growth Factor Receptor (FGFR) signaling and MAK/ICK:
FGFR-MAK interaction: MAK and its homolog ICK coimmunoprecipitate with FGFR3, and ICK also interacts with FGFR1 and FGFR4, but not FGFR2 .
Phosphorylation dynamics: When investigating this relationship, researchers should:
Functional consequences: Evidence suggests that FGFR-mediated phosphorylation may actually inhibit ICK/MAK kinase activity by approximately 30%, despite causing accumulation of the protein . This counterintuitive relationship should be carefully examined using phospho-specific antibodies to track the dynamic regulation.
When working with phospho-specific antibodies, several challenges may arise:
Specificity considerations: Ensure antibody specificity by:
Signal optimization: For optimal Western blot results:
Blocking conditions: Use 5% non-fat milk in TBS for blocking membranes for approximately 1.5 hours at room temperature .
To maximize research insights:
Complementary techniques:
Multi-antibody approach: Use antibodies recognizing:
Pathway integration: Since MAK relates to primary cilium function and FGFR signaling , consider studying these connections using:
Co-immunoprecipitation to confirm protein interactions
Inhibitors of FGFR to assess effects on MAK Y159 phosphorylation
Ciliary markers to correlate MAK phosphorylation with ciliary phenotypes
Recent research indicates connections between MAK/ICK and primary cilium function:
Functional significance: A properly functioning primary cilium is prerequisite for both normal development and aging in ciliated organisms, including humans .
Research approach: Investigate this connection by:
Examining changes in MAK Y159 phosphorylation during ciliogenesis
Correlating phosphorylation status with ciliary length and function
Assessing how disruption of Y159 phosphorylation affects ciliary phenotypes
Disease relevance: Given that ciliopathies represent an important class of genetic disorders, understanding how MAK phosphorylation contributes to ciliary regulation could have significant clinical implications.
Beyond Y159, MAK contains multiple phosphorylation sites:
Comparative analysis: Research indicates several conserved tyrosines in ICK/MAK that can be phosphorylated by FGFR3, including Y15, Y156, Y495, and Y555 .
Structural implications: The location of these phosphorylation sites within the protein structure has functional consequences:
Investigative approach: To understand the coordination between multiple phosphorylation events:
Use phospho-specific antibodies to monitor different phosphorylation sites
Create combination mutants to assess functional interplay
Employ proteomics approaches to identify all relevant phosphorylation sites